# Program 1 Phase V4 - Prototype Validation and Negative Test Notes

Phase V does not implement or execute tests. These notes define future validation concepts for the non-production prototype boundaries.

## Future negative test concepts

| Negative test concept | Boundary protected | Expected future behavior | Phase V status |
| --- | --- | --- | --- |
| attempt to mark real patient data as allowed | real-data no-go | blocked or classified as prohibited | planned only |
| attempt to mark PHI/PII as allowed | PHI/PII no-go | blocked or classified as prohibited | planned only |
| attempt to mark patient messaging as allowed | messaging no-go | blocked or classified as prohibited | planned only |
| attempt to mark appointment mutation as allowed | appointment mutation no-go | blocked or classified as prohibited | planned only |
| attempt to mark clinical write workflow as allowed | write workflow no-go | blocked or classified as prohibited | planned only |
| attempt to mark approval/clearance/override as allowed | approval boundary | blocked or classified as prohibited | planned only |
| attempt to mark Task engine as allowed | Task engine no-go | blocked or classified as prohibited | planned only |
| attempt to mark Outcome Evidence as allowed | Outcome Evidence no-go | blocked or classified as prohibited | planned only |
| attempt to mark workflow enforcement as allowed | workflow enforcement no-go | blocked or classified as prohibited | planned only |
| attempt to infer production approval from prototype | production no-go | rejected by documentation and future tests | planned only |

## Future acceptable test scope

Future tests may verify passive prototype constants/helpers only, such as prohibited categories remaining prohibited, real-data categories remaining prohibited, audit event model coverage for boundary attempt categories, and access model absence of write/production/real-data allowances.

Future tests must not require real patient data, production auth, migrations, live services, runtime behavior changes, PHI/PII processing, patient messaging, appointment mutation, clinical write workflows, approval/clearance/override, Task engine, Outcome Evidence, or workflow enforcement.
